RecruitingNCT06612541

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Sponsor

Vanderbilt University Medical Center

Enrollment

90 participants

Start Date

Feb 1, 2025

Study Type

OBSERVATIONAL

Conditions

Retinopathy of Prematurity (ROP)ROP Examination

Summary

The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.

Eligibility

Min Age: 24 WeeksMax Age: 34 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with rop examination and retinopathy of prematurity (rop). The study is currently recruiting participants at 1 location. People eligible for this study include aged 24 Weeks to 34 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.